Global Health Investment Corporation

Investing in a Healthier and Safer World

Global Health Investment Corporation (GHIC) is a nonprofit organization catalyzing the development of technologies to improve human health worldwide.

 A large group of people in a marketplace, some in traditional dress and some not, in south Asia.


For nearly a decade, the Global Health Investment Corporation (GHIC) has been financing innovations in healthcare and life sciences. We pursue a double bottom line investment model to accelerate the development of technologies with the potential to both improve public health and generate financial returns. We strive to ensure that the technologies we support will be developed and made accessible to people who need them.

The COVID-19 pandemic clearly demonstrates how interconnected health outcomes are throughout the world. But it is just the latest example. Outbreaks of existing and emerging infectious diseases are inevitable, but we must stop them from becoming pandemics. Our goal is to address today’s global health and health security challenges, anticipate those of tomorrow, and invest in innovations that will lead to a healthier and safer world—for all of us.

Read about GHIC

Investment Portfolio

Our investments focus on strengthening global health security and addressing other global health challenges, including infectious disease threats and maternal and child health.

See our portfolio

Global Health Investment Fund 

Our namesake $108 million social impact investment fund (GHIF) has invested in twelve companies developing interventions such as diagnostics, devices, vaccines and therapeutics that target diseases that are most prevalent in low- and middle-income countries, such as HIV/AIDS, malaria, tuberculosis and cholera. The fund’s portfolio companies have successfully commercialized more than a dozen products that have been delivered to over 100 million people, improving and saving lives.


Our new partnership with the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary of Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services, uses venture capital practices to develop and commercialize technologies and medical products that respond to or prevent public health emergencies, such as pandemics and other global health security threats.

"Pathogens and health security threats constantly evolve. To combat them, we need to tap the most novel and impactful ideas in the entrepreneurial community." – BARDA Director, Gary Disbrow, PhD

Our Partners

Our strategic partners and investors include leading philanthropic, public and private sector institutions. Many are pioneers in the field of global health impact investment, and others have joined more recently as we expand our mission to include global health security and pandemic preparedness. Together, we’re improving global health and investing in a healthier, safer world.

Strategic Partners

Bill & Melinda Gates Foundation Federal Ministry for Economic Cooperation and Development KFW - Bank aus Verantwortung
BARDA DRIVe - Transforming Health Security


Children's Investment Fund Foundation Grand Challenges Canada IFC Sida Glaxo Smith Kline Merck The Pfizer Foundation Axa Investment managers JP Morgan Chase Storebrand